(Q52241572)

27 April 2018

title

Effects of amiodarone and its active metabolite desethylamiodarone on the ventricular defibrillation threshold. (English)

1 reference

27 April 2018

1 reference

Zhou L

1

1 reference

27 April 2018

Chen BP

2

1 reference

27 April 2018

Kluger J

3

1 reference

27 April 2018

Fan C

4

1 reference

27 April 2018

Chow MS

5

1 reference

27 April 2018

language of work or name

English

0 references

publication date

1 June 1998

1 reference

27 April 2018

Journal of the American College of Cardiology

published in

1 reference

27 April 2018

volume

31

1 reference

27 April 2018

issue

7

1 reference

27 April 2018

page(s)

1672-1678

1 reference

27 April 2018

Long-term outcome with the automatic implantable cardioverter-defibrillator.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900160-0

7 January 2021

Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900160-0

7 January 2021

Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900160-0

7 January 2021

Reduction in sudden death and total mortality by antiarrhythmic therapy evaluated by electrophysiologic drug testing: criteria of efficacy in patients with sustained ventricular tachyarrhythmia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900160-0

7 January 2021

Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs. Sodium channel block and action potential prolongation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900160-0

7 January 2021

Lidocaine causes a reversible, concentration-dependent increase in defibrillation energy requirements.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900160-0

7 January 2021

Drug-device interactions: clinical considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900160-0

7 January 2021

Amiodarone-induced refractoriness to cardioversion

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900160-0

7 January 2021

The implanted defibrillator: relation of defibrillating lead configuration and clinical variables to defibrillation threshold

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900160-0

7 January 2021

Effect of amiodarone on ventricular fibrillation and defibrillation thresholds in the canine heart under normal and ischemic conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900160-0

7 January 2021

Effects of acute intravenous and chronic oral amiodarone on defibrillation energy requirements

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900160-0

7 January 2021

The effect of chronic oral and acute intravenous amiodarone administration on ventricular defibrillation threshold using implanted electrodes in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900160-0

7 January 2021

Relation between amiodarone and desethylamiodarone plasma concentrations and ventricular defibrillation energy requirements

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900160-0

7 January 2021

A comparison of the electrophysiologic effects of intravenous and oral amiodarone in the same patient

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900160-0

7 January 2021

Acute and chronic effects of amiodarone on ventricular refractoriness, intraventricular conduction and ventricular tachycardia induction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900160-0

7 January 2021

Effect of amiodarone on conduction and refractoriness of the His-Purkinje system in the human heart

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900160-0

7 January 2021

QT prolongation and the antiarrhythmic efficacy of amiodarone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900160-0

7 January 2021

Pharmacodynamics of Intravenous Amiodarone in the Dog

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900160-0

7 January 2021

Electrophysiologic effects of amiodarone: experimental and clinical observation relative to serum and tissue drug concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900160-0

7 January 2021

Comparative electrophysiologic effects of intravenous amiodarone and desethylamiodarone in dogs: evidence for clinically relevant activity of the metabolite

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900160-0

7 January 2021

Analysis of amiodarone and desethylamiodarone in serum and tears by reversed-phase high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900160-0

7 January 2021

Pharmacology and pharmacokinetics of amiodarone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900160-0

7 January 2021

The historical development, cellular electrophysiology and pharmacology of amiodarone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900160-0

7 January 2021

Effects of chronic amiodarone therapy on defibrillation threshold

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900160-0

7 January 2021

Acute effects of intravenous propafenone on the internal ventricular defibrillation threshold in the anesthetized dog

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900160-0

7 January 2021

Effect of recainam on the energy required for ventricular defibrillation in dogs as assessed with implanted electrodes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900160-0

7 January 2021

Effects of amiodarone and its metabolite, desethylamiodarone, on the electrophysiologic properties of isolated cardiac muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900160-0

7 January 2021

Block of inactivated sodium channels and of depolarization-induced automaticity in guinea pig papillary muscle by amiodarone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900160-0

7 January 2021

Use-dependent effects of amiodarone on Vmax in cardiac Purkinje and ventricular muscle fibers

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900160-0

7 January 2021

Oral clofilium produces sustained lowering of defibrillation energy requirements in a canine model

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900160-0

7 January 2021

Mechanism of antiarrhythmic drug-induced changes in defibrillation threshold: role of potassium and sodium channel conductance.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900160-0

7 January 2021

Adrenergically mediated variations in the energy required to defibrillate the heart: observations in closed-chest, nonanesthetized dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900160-0

7 January 2021

Effects of lidocaine and verapamil on defibrillation in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900160-0

7 January 2021

Differential effects of lidocaine on defibrillation threshold with monophasic versus biphasic shock waveforms.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900160-0

7 January 2021

Patients with a high defibrillation threshold: clinical characteristics, management, and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900160-0

7 January 2021

10.1016/S0735-1097(98)00160-0

Identifiers

DOI

1 reference

27 April 2018

PubMed ID

9626850

1 reference

27 April 2018